BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6191172)

  • 41. [Carcinoembryonic antigen (CEA), serum amylase and pancreozymin-secretin test in relation to stages of pancreatic cancer].
    Kozu T; Imaizumi T; Hanyu F; Takeuchi T; Nakamura K; Oi I; Toki F; Fukushima Y; Tomatsu S; Yoshikawa T
    Gan No Rinsho; 1983 Aug; 29(10):1104-10. PubMed ID: 6195362
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Malignant tumors of the corpus uteri. Immunology and malignant tumors].
    Danesino V
    Minerva Ginecol; 1976 Mar; 28(3):208-11. PubMed ID: 62329
    [No Abstract]   [Full Text] [Related]  

  • 43. [Tumor markers in the diagnosis of tumors in the subhepatic area].
    Dufek V; Petrtýl J; Klener P; Chmel J
    Vnitr Lek; 1994 Jun; 40(6):350-3. PubMed ID: 8073643
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The tumor-associated antigen CA 19-9 in the differential diagnosis and course control of malignancies of the pancreas and the gastrointestinal tract].
    Klapdor R; Greten H
    Dtsch Med Wochenschr; 1984 Dec; 109(50):1935-9. PubMed ID: 6210188
    [No Abstract]   [Full Text] [Related]  

  • 45. [Immunological methods in tumor diagnosis].
    Jaquet H; Mach JP; Pettavel J
    Verh Dtsch Ges Inn Med; 1978; (84):567-72. PubMed ID: 84451
    [No Abstract]   [Full Text] [Related]  

  • 46. [Tumor marker in lung cancer].
    Shijubo N; Abe S
    Kokyu To Junkan; 1993 Jun; 41(6):551-5. PubMed ID: 7687790
    [No Abstract]   [Full Text] [Related]  

  • 47. Biochemical and immunologic diagnosis of cancer. Pancreatic and gastric cancer.
    Burtin P
    Tumour Biol; 1987; 8(2-3):84-5. PubMed ID: 2452469
    [No Abstract]   [Full Text] [Related]  

  • 48. [Tumor markers. Current use in antineoplastic strategy].
    Manguso L; Musset M; Coraggio F; Grimaldi G; Zito GA; Gattoni A; Catalano G; Astarita C; Papaleo G; Di Domenico M
    Clin Ter; 1984 Aug; 110(3):231-41. PubMed ID: 6207976
    [No Abstract]   [Full Text] [Related]  

  • 49. New screening and diagnostic tests for prostate cancer and immunologic assessment.
    Catalona WJ; Menon M
    Urology; 1981 Mar; 17(Suppl 3):61-5. PubMed ID: 6163244
    [No Abstract]   [Full Text] [Related]  

  • 50. [Tumor antigens].
    Höffken K; Schmidt CG
    Dtsch Med Wochenschr; 1978 Jul; 103(30):1187-90. PubMed ID: 78790
    [No Abstract]   [Full Text] [Related]  

  • 51. The value of laboratory tests in the diagnosis and treatment of malignant liver tumours.
    Bergan A; Sundblad R
    Ann Chir Gynaecol Suppl; 1986; 200():33-4. PubMed ID: 2425696
    [No Abstract]   [Full Text] [Related]  

  • 52. [Carcinoembryonic antigen and alpha-fetoprotein in stomach cancer].
    Gitel'man LG
    Med Radiol (Mosk); 1983 Feb; 28(2):81-3. PubMed ID: 6188022
    [No Abstract]   [Full Text] [Related]  

  • 53. How to characterize human cancer antigens.
    Burtin PH
    Antibiot Chemother (1971); 1978; 22():1-4. PubMed ID: 74971
    [No Abstract]   [Full Text] [Related]  

  • 54. [Possibilities of laboratory diagnosis of liver cancer].
    Pastrakuljić N
    Srp Arh Celok Lek; 1984; 112(7-8):879-80. PubMed ID: 6084310
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical significance of present tumor markers].
    Ohkura H
    Gan To Kagaku Ryoho; 1993 May; 20(7):843-9. PubMed ID: 7683865
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunological diagnosis of pancreatic cancer by assaying carcinoembryonic antigen (CEA) in pure pancreatic juice.
    Nishida K; Yoshikawa T; Kondo M; Thiele HG
    Hepatogastroenterology; 1980 Dec; 27(6):488-94. PubMed ID: 7203382
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Studies on the methods of diagnosing pancreatic cancer with the use of tumor markers by discriminant analysis].
    Kawanishi M; Fujita S; Kunita S; Furukawa Y; Yamada H; Nakamura M; Kajiyama G
    Nihon Shokakibyo Gakkai Zasshi; 1985 Jul; 82(7):1731-41. PubMed ID: 3878419
    [No Abstract]   [Full Text] [Related]  

  • 58. [Immunodiagnosis of tumors].
    Abelev GI
    Vestn Akad Med Nauk SSSR; 1982; (12):61-5. PubMed ID: 6186101
    [No Abstract]   [Full Text] [Related]  

  • 59. Establishment and characterization of a seminoma cell-line (S2).
    von Keitz AT; Riedmiller H; Neumann K; Gutschank W; Fonatsch C
    Investig Urol (Berl); 1994; 5():28-31. PubMed ID: 7536523
    [No Abstract]   [Full Text] [Related]  

  • 60. Oncofetal antigens as tumor markers in the cytologic diagnosis of effusions.
    Orell SR; Dowling KD
    Acta Cytol; 1983; 27(6):625-9. PubMed ID: 6196931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.